HIGHLIGHTS
- who: August and colleagues from the Shanghai Jiao Tong, China have published the Article: A network-based pharmacological investigation to identify the mechanistic regulatory pathway of andrographolide against colorectal cancer, in the Journal: (JOURNAL)
- what: The aim of this study was to provide insight into the mechanism responsible for the anticancer properties of andrographolide in CRC by using network pharmacology which involves investigating the links between the drug, targets, and its pathway.
- future: To clarify the relationship between andrographolide and hub genes along with the specific mechanisms underlying those actions more pre and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.